Urology

Medicine & Life Sciences

1. Prostatic Neoplasms 100%
2. Urinary Bladder Neoplasms 92%
3. Urinary Bladder 91%
4. Prostatic Hyperplasia 86%
5. Prostate 79%
6. Kidney 74%
7. Neoplasms 66%
8. Nephrectomy 64%
9. Lower Urinary Tract Symptoms 62%
10. Renal Cell Carcinoma 58%
11. Carcinoma 56%
12. Cystectomy 49%
13. Stress Urinary Incontinence 45%
14. Recurrence 41%
15. Prostatectomy 40%
16. Therapeutics 39%
17. Urodynamics 38%
18. Nephroureterectomy 38%
19. Robotics 36%
20. Survival 33%
21. Prostate-Specific Antigen 33%
22. Urology 33%
23. Dutasteride 27%
24. Urinary Tract 25%
25. Urologists 24%
26. Radiofrequency Ablation 24%
27. Artificial Urinary Sphincter 23%
28. Urethral Stricture 22%
29. Costs and Cost Analysis 22%
30. Laparoscopy 21%
31. Urine 21%
32. Vesico-Ureteral Reflux 21%
33. Pediatrics 21%
34. Urethra 20%
35. Placebos 19%
36. Androgen Receptors 19%
37. Suburethral Slings 19%
38. Biopsy 19%
39. Biomarkers 19%
40. Neoplasm Metastasis 18%
41. Androgens 17%
42. Urinary Incontinence 17%
43. Penile Prosthesis 17%
44. Cystoscopy 17%
45. Pathologic Constriction 17%
46. Child 17%
47. Drug Therapy 16%
48. Nomograms 16%
49. Ureter 16%
50. Quality of Life 16%
51. Lymph Nodes 16%
52. Wounds and Injuries 16%
53. Hydronephrosis 16%
54. Finasteride 16%
55. Transitional Cell Carcinoma 15%
56. Pressure 15%
57. Surgeons 15%
58. Safety 15%
59. Genes 15%
60. Tamsulosin 15%
61. Lymph Node Excision 14%
62. Swine 14%
63. Urinary Tract Infections 14%
64. Prolapse 14%
65. Growth 14%
66. Urinary Retention 13%
67. Ureteroscopy 13%
68. Kidney Calculi 13%
69. Transurethral Resection of Prostate 13%
70. Overactive Urinary Bladder 13%
71. Lithotripsy 12%
72. Urinary Bladder Neck Obstruction 12%
73. Guidelines 12%
74. Erectile Dysfunction 12%
75. Equipment and Supplies 12%
76. Serum 12%
77. Urinary Diversion 12%
78. Transplants 12%
79. Morbidity 11%
80. Testis 11%
81. Cell Biology 11%
82. Proteins 11%
83. Pelvic Organ Prolapse 11%
84. Tadalafil 10%
85. Testosterone 10%
86. Technology 10%
87. Incidence 10%
88. Operative Time 10%
89. Castration 10%
90. Population 10%
91. Urolithiasis 10%
92. Cost-Benefit Analysis 10%
93. Nephrolithiasis 10%
94. Percutaneous Nephrolithotomy 9%
95. Kidney Neoplasms 9%
96. Neurogenic Urinary Bladder 9%
97. Hypospadias 9%
98. Hematuria 9%
99. Mortality 9%
100. Penile Induration 9%